First-ever AACR-sponsored clinical trial will test whether biomarker-directed treatment approaches can help patients skip surgery and preserve their organs...
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses PHILADELPHIA – A...
PHILADELPHIA – Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant...
The comment period for the OMB’s proposed changes closes at 11:59 p.m. Monday, July 13. PHILADELPHIA – The American...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Matthew Vander Heiden, MD, PhD, Fellow...
Report features latest statistics, including promising signs of progress, and 10 compelling personal stories PHILADELPHIA – The American Association...
CA19-9 is a biomarker whose levels often correlate with pancreatic cancer stage and prognosis PHILADELPHIA – A dual-threshold model...
PHILADELPHIA – The American Association for Cancer Research (AACR) today thanked Emerging Frontiers in Oncology (EFO) for its support...
SAN DIEGO – Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more...
The treatment preserved quality of life SAN DIEGO – Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to...